Susan Carr - Böcker

"The contents are not specifically nursing orientated but very neatly balanced to be of relevance to all working in the public health arena…the book is well written, the language is clear, and the concepts clearly and simply explained and easily understood" Journal of Biosocial ScienceWhat are epidemiology and public health?What is the nature of public health evidence and knowledge?What strategies can be used to protect and improve health? The second edition of this bestselling book provides a multi-professional introduction to the key concepts in public health and epidemiology. It presents a broad, interactive account of contemporary public health, placing an emphasis on developing public health skills and stimulating the reader to think through the issues for themselves.

The new edition features additional material on:

Historical perspectivesPublic health skills for practiceEvaluation of public health interventions The nature of evidence and public health knowledge Translating policy and evidence into practice An Introduction to Public Health and Epidemiology is key reading for students of public health and healthcare professionals, including: nurses, doctors, community development workers and public health workers.

This book examines the conditions under which non-governmental organisations (NGOs) may exert influence on policies to conserve and sustainably use natural resources in sub-Saharan Africa. The book is unique in bringing together NGO campaigners in three African countries with academics specialising in development studies, systems and environmental policy.

Europe was told that it had no choice but to accept agbiotech, yet this imperative was turned into a test of democratic accountability for societal choices. Since the late 1990s, European public controversy has kept the agri-biotech industry and its promoters on the defensive. As some opponents and regulators alike have declared, ‘GM food/crops are on trial’. Suspicion of their guilt has been evoked by moral symbols, as disputes over whether genetically-modified products are modest benign improvements on traditional plant breeding, or dangerous Frankenfoods; and in disputes over whether they are global saviours, or control agents of multinational companies. This book examines European institutions being ‘put on trial’ for how their regulatory procedures evaluate and regulate GM products, in ways which opened up alternative futures. Levidow and Carr highlight how public controversy created a legitimacy crisis, leading to national policy changes and demands, in turn stimulating changes in EU agbiotech regulations as a strategy to regain legitimacy.

Europe was told that it had no choice but to accept agbiotech, yet this imperative was turned into a test of democratic accountability for societal choices. Since the late 1990s, European public controversy has kept the agri-biotech industry and its promoters on the defensive. As some opponents and regulators alike have declared, ‘GM food/crops are on trial’. Suspicion of their guilt has been evoked by moral symbols, as disputes over whether genetically-modified products are modest benign improvements on traditional plant breeding, or dangerous Frankenfoods; and in disputes over whether they are global saviours, or control agents of multinational companies. This book examines European institutions being ‘put on trial’ for how their regulatory procedures evaluate and regulate GM products, in ways which opened up alternative futures. Levidow and Carr highlight how public controversy created a legitimacy crisis, leading to national policy changes and demands, in turn stimulating changes in EU agbiotech regulations as a strategy to regain legitimacy.